Le professeur Massimo Falconi est un oncologue gastro-intestinal spécialisé dans les maladies du pancréas depuis plus de 30 ans. Il exerce à l'Ospedale San Raffaele de Milan et a réalisé 3 600 interventions chirurgicales, dont des pancréatectomies distales, totales et moyennes, des résections pancréatiques et des énucléations. Il est directeur de la chirurgie pancréatique et de l'unité clinique et translationnelle du pancréas à l'IRCCS Ospedale San Raffaele et possède une expérience internationale au Japon, en Espagne, en Allemagne et en Suède. Le professeur Falconi a écrit plus de 330 articles et participé à plus de 350 conférences italiennes et 220 conférences internationales, et il est membre de plusieurs organisations.
Lire la suiteProf. Filippini began his career in 1980 and has been teaching at the University of Chieti since the 1990s in the fields of General Surgery, Microsurgery, Reconstructive Surgery, Vascular Surgery, Orthopedics, and Gynecology. His primary focus is oncological surgery, particularly specializing in "The surgical treatment of locally advanced tumors and multi-organ resections." He has enriched his expertise by visiting prominent reference centers in the United States, including the Memorial Sloan Kettering Cancer Center in Manhattan, New York City. There, he delved into minimally invasive, laparoscopic, and microsurgical techniques under the guidance of esteemed mentors such as John Daly, Michele Gagner, and Murray Brennan. Additionally, in 2005, he further expanded his skills at the City of Hope Oncology Center in Los Angeles, focusing on robotic surgery in oncology.
In 1980, Prof. Filippini graduated in Medicine and Surgery from the G. D'Annunzio University of Chieti in Italy with honors, presenting an experimental thesis on lympho-venous anastomosis using microsurgical techniques. He completed his specialization in general surgery at the University of Pisa with distinction after five years. In 1990, he obtained another specialization in Plastic and Reconstructive Surgery from the University of Padua in Italy, where he maintained a stellar academic record.
Prof. Filippini has presented at numerous national and international conferences and authored over 100 scientific publications. Additionally, he has co-authored two monographs.
Lire la suiteProf. Deraco started his professional career in 1989, as Associated Researcher at the Surgery Dept. and Experimental Oncology Dept. at the Fondazione IRCCS (National Cancer Institute) Milan, Italy, where he then became a part of the surgical team holding more roles: for over 10 years he had been the responsible doctor for Peritoneal Surface Malignancies Program, then, from 2017 he’s the director on Peritoneal Surface Malignancies Unit, and from 2015 he is also a Director of the ESPSO (European School of Peritoneal Surface Oncology). He also works as a Professor of Peritoneal Surface Malignancy, General Surgery, at the Milan University. Prof. Deraco is an expert of Cytoreducyive Surgery (CRS), Hiperthermic Intra Peritoneal Chemotherapy (HIPEC) and Pressurised Intra Peritoneal Aerosolized Chemotherapy (PIPAC), having treated, with these techniques, more than 1.200 patients with PSM.
Education
In 1987, Prof. Deraco graduated in Medicine and Surgery from the University of Messina, Italy with full marks, where 5 years later she specialized in General Surgery. In 1993 he obtained another specialization, in Oncology, from the Paris Dauphine University, France. In the years 1991-93 he obtained a 3-years research fellow supported by the Research Italian Ministry carried out at the Surgery Dept. at the "Gustave Roussy Institut" Villejuif, France and Surgery Dept. at "The Royal Marsden Hospital" London, UK. Then, in 1996, he spent a Fellowship of AIRC (Italian Association of Cancer Research) carried out at the Surgical Department of "Washington Cancer Institute” at the Washington Hospital Center, Washington DC, USA.
Research & Publications
Having held important academic positions throughout all the years his career, Prof. Deraco has always been actively engaged in the research, in the field of Peritoneal Surface Malignancy, Oncological Surgery. In 2013 he obtained the Italian National Scientific Habilitation as 1st and 2nd Level Professor of General Surgery. From 2010 to 2015 he taught Peritoneal Surface Malignancy at the Rome University Tor Vergata, School on Surgery of the Digestive Tract, from 2015 he works as a Professor of Peritoneal Surface Malignancy, General Surgery, at the Milan University. He taught Peritoneal Surface Malignancy Treatment Techniques for other several Italian and foreign institutions, where had also been an academic mentor for over 30 postdoctoral fellows from McGill University, Montreal, Canada; National Cancer Institute – ESE, Bogotá, Colombia; University Hospital Reina Sofia, Spain among others. He has published more than 250 indexed scientific articles and 25 book chapters with h-index = 53.
Prof. Deraco was engaged in scientific activity, as the executive member of the board of different scientific societies, such as SITILO (Italian Society for Loco Regional Cancer Therapy); GIM (Italian Mesothelioma Group); PSOGI (Peritoneal Surface Oncology International Group); IART (Italian Association for Rare Tumors); ESSO (European Society of Surgical Oncology) etc.
Prof. Deraco has been Scientific Director of many events including the PSOGI Consensus Conference in 2006 and Chair of the upcoming XIII PSOGI Congress (Venice October 2023). He is a member of the Steering Committee for the Italian AIOM guidelines and PSOGI guidelines on Peritoneal Surface Malignancies.
As Principal Investigator or Co-Investigator he has conducted multiple international and national research projects, eligible for funding on the basis of competitive calls for peer review. He is currently Principal or Co-Investigator of several research projects on Peritoneal Mesothelioma, Colorectal Cancer, Appendiceal Cancer and Pseudomixoma Peritonei, one of which is international (Accelerator Award).
Lire la suiteDr. Ayman is a Medical Doctor and Surgeon specializing in General and Bariatric Surgery, with extensive training and experience in minimally invasive surgery and obesity management.
Doctor earned his Master's Degree in Medicine and Surgery from the University of Brescia in 2005. He then completed his specialization in General Surgery at the same university in 2016, with a thesis titled "Fast track in minimally invasive colon surgery. He has complete autonomy in the clinical management of complex patients and extensive experience in performing a variety of surgical procedures, including major surgeries. His expertise includes gastric and colorectal surgery, bariatric surgery, abdominal wall surgery, videolaparoscopic (VLC) and laparotomic (VLA) procedures, and proctology. He is particularly skilled in performing medium and major surgeries in emergency settings.
Currently, he practices at Maria Cecilia Hospital in Bologna, where he evaluates the degree of obesity and associated conditions. Based on these assessments, he determines the most suitable surgical intervention, such as sleeve gastrectomy, gastric bypass, and mini laparoscopic bypass.
He has advanced training in colorectal and abdominal wall surgery from top institutions in Italy and Belgium.
He is an active member of the Italian Society of Obesity Surgery and Metabolic Disorders (S.I.C.OB.) and the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO), contributing to the advancement of bariatric surgery on an international level.
Dr. Ayman is distinguished by his dedication to patient care and his advanced skills in minimally invasive and bariatric surgery.
Lire la suiteDr Braun's primary responsibilities include direct leadership and execution of complex surgeries, including gastric bypass, sleeve gastrectomy, and other advanced metabolic and bariatric procedures. He has developed solid experience in managing the different clinical challenges present in obese patients, providing them with personalized and optimized care to ensure positive long-term outcomes.
His surgical practice is based on an in-depth methodology and a careful look at the latest technological innovations in the field of bariatric surgery. He has actively worked to implement advanced protocols and continually improve operational techniques, while maintaining the highest standards of patient safety and care.
With over 2000 operations performed as a surgeon specializing in oncology, he has developed extensive experience and expertise in laparoscopic and robotic surgery applied to the care of cancer patients.
As a primary operator, he has successfully conducted a wide range of laparoscopic and robotic surgeries for the treatment of oncological conditions, including gastrointestinal, urological, gynecological and other solid tumors. His surgical practice has focused on the application of advanced techniques, using cutting-edge laparoscopic instruments and robotic systems
Lire la suiteLe professeur Carlo Castroro est directeur de l'unité de chirurgie générale gastrique et œsophagienne de l'hôpital de recherche Humanitas. Il est diplômé de l'Université de Padoue et spécialisé en médecine générale et chirurgie thoracique.
Domaines d’intérêt médicaux :
Experience precedente:
Chef de l'Unité Départementale Simple de Chirurgie Oncologique de l'« Istituto Oncologico Veneto », IOV - IRCCS, Padoue.
Domaines d’intérêt de recherche :
Expérience d'enseignement : Il est professeur à l' École supérieure de chirurgie générale de l'Université de Padoue et a également participé en tant que chargé de cours à de nombreuses formations postuniversitaires dans le domaine de la chirurgie de l'œsophage, de la chirurgie ambulatoire et de la chirurgie mini-invasive.
Prof. Alessio Michele Goffredo Aghemo est ledirecteur de l'unité d'hépatologie à l'hôpital de recherche Humanitas.
Domaines d'intérêt médicaux:
Previous experience:
De 2007 à 2017, il a été directeur médical de 1er niveau à l'U.O de gastroentérologie de la Fondation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan.
Domaines d'intérêt en recherche:
Activité clinique et de recherche centrée sur l'histoire naturelle et le traitement des hépatites virales.
Il est l'auteur de 155 publications évaluées par les pairs (Impact Factor total 1151,3, H-Index 25 selon Scopus, H-Index 20 dernières 5 années Scopus, H-Index 30 selon Google Scholar) (mise à jour septembre 2017).
De 2013 à 2016, il a été membre scientifique du conseil d'administration de l'Association européenne pour l'étude du foie (EASL).
Depuis 2016, il est membre du comité scientifique de l'Association européenne de gastroentérologie (UEG).
Il est membre de la commission de l'AISF (Association italienne pour l'étude du foie) pour les médicaments antiviraux dirigés contre le VHC (2012-présent). Depuis 2016, il en est le coordinateur.
Il est expert AIFA/EMEA pour les maladies du foie depuis 2008.
Membre du Comité exécutif du Réseau régional VHC, déterminé par la Région Lombardie le 28 septembre 2015.
Il a participé en tant qu'expert à la rédaction des lignes directrices européennes 2013-2014-2015-2016-2017 (EASL) et italiennes (AISF) sur le traitement de l'hépatite C chronique.
Expérience d'enseignement:
Il est professeur associé de gastroentérologie à l'université Humanitas depuis septembre 2017.
Lire la suite
Le professeur Alessandro Repici est le directeur de l'unité de gastro-entérologie et d'endoscopie digestive à l'hôpital de recherche Humanitas. Diplômé en médecine et en chirurgie en 1990, il obtient l'année suivante une bourse d'études au service de gastro-entérologie de l'hôpital Molinette de Turin, où il commence à pratiquer l'endoscopie digestive. En 1992, il a travaillé avec le professeur Claude Liguory en tant que boursier à l'Hôpital américain de Paris.
En 1994, il est devenu spécialiste en gastro-entérologie et en endoscopie digestive à l'Université de Messine et a travaillé dans le service de gastro-entérologie de l'Ospedale Maggiore Molinette de Turin.
Dans les années suivantes, il a travaillé au service d'endoscopie digestive de l'hôpital Altona de Hambourg, dirigé par le professeur Hagenmuller, et au service de gastroentérologie de l'hôpital Molinette de Turin, dirigé par le professeur Rizzetto. Rizzetto. En 1999, il a été chercheur au Centre d'endoscopie oncologique et opératoire de l'hôpital Wellsley à Toronto.
Il enseigne la gastro-entérologie et l'endoscopie digestive à l'École de spécialisation en oncologie depuis 2000, à l'Université de Turin depuis 2004 et les techniques de diagnostic et les opérations d'endoscopie à l'École de spécialisation en chirurgie générale I et II de l'Université de Turin.
L'activité clinique et la recherche du Prof. Repici se concentre principalement sur le développement de nouvelles techniques endoscopiques dans le domaine du diagnostic et de la thérapie, avec une attention particulière aux nouvelles méthodes d'ablation endoscopique des lésions cancéreuses et à la palliation précoce des tumeurs malignes gastro-intestinales avancées.
Prof. Repici est coordinateur, investigateur principal et co-investigateur dans plus de 50 études, y compris de phase II et III pour l'approbation par la FDA et l'EMA de nouvelles molécules et de nouveaux instruments pour l'endoscopie diagnostique et opérationnelle.
Prof. Repici collabore à des projets de recherche dans le domaine de l'endoscopie avec l'Université de Rotterdam, à Haïfa, à New York et avec plusieurs centres italiens. Il est membre de plusieurs sociétés scientifiques nationales et internationales de gastroentérologie et d'endoscopie digestive.
Publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=repici+alessandro
Lire la suite